口蹄疫SAT2疫苗可保护猪抵御同源病毒株的实验性攻击,不论该物种中病原性是否轻微
为评估SAT2型口蹄疫灭活疫苗对猪同源攻击的保护效果,将适应猪的SAT2攻击株经两次传代后感染两组各5头猪,一组于攻击前28天接种疫苗,另一组为未接种对照。至少80%接种猪获得临床疾病保护,且接种猪均未检出病毒排出。
要点
- 至少80%接种猪获得临床疾病保护。
- 接种猪中均未观察到病毒排出。
- 实验接种猪可感染SAT2血清型。
核心结论
- 本研究表明实验接种猪可感染SAT2血清型,疫苗接种可提供针对全身化和病毒排出的保护,确认疫苗作为猪口蹄疫控制重要工具的潜力。
研究设计与样本
- 将SAT2型口蹄疫攻击株在猪中传代两次后,感染两组各5头猪;第一组于攻击前28天接种疫苗,另一组为未接种对照。
主要发现
- 至少80%的接种猪获得针对临床疾病的保护。
- 接种猪中均未观察到病毒排出。
- 实验接种猪可感染SAT2血清型。
临床怎么用
- 原文结论认为疫苗接种可提供针对全身化和病毒排出的保护,确认其作为猪口蹄疫控制重要工具的潜力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
FMDV serotype SAT2 is most frequently associated with outbreaks in ruminants. However, the risk of it spreading from cattle to pigs cannot be excluded. To assess the efficacy of an SAT2-type FMD inactivated vaccine against homologous challenge in pigs, a suitable challenge strain adapted to pigs was produced. After two passages in two pigs each, a FMDV stock of SAT2 challenge strain was produced. This material was used to infect two groups of five pigs. The first group being vaccinated 28 days before challenge and the other one left as an unvaccinated control. Clinical signs were recorded, virus shedding was assessed on mouth swabs, and neutralising antibody titres were determined. At least 80% of the vaccinated pigs were protected against clinical disease. Furthermore, no virus shedding was observed in any of the vaccinated pigs. This study shows that experimentally inoculated pigs can become infected with a SAT2 serotype. Furthermore, vaccination offers protection against generalisation and viral excretion, confirming the potential of vaccination as an important tool in the control of FMD in pigs.
引用
- Mouton L, Dekker A, Bleijenberg M, et al. A foot-and-mouth disease SAT2 vaccine protects swine against experimental challenge with a homologous virus strain, irrespective of mild pathogenicity in this species. Vaccine. 2018. PMID: 29510916. doi:10.1016/j.vaccine.2018.02.096
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。